{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:48:29Z","timestamp":1777661309439,"version":"3.51.4"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T00:00:00Z","timestamp":1735603200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institutes of Health, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI135561"],"award-info":[{"award-number":["R21AI135561"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institutes of Health, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K01AI168587"],"award-info":[{"award-number":["K01AI168587"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,7,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Enteric fever caused by Salmonella enterica serovars Typhi and Paratyphi A in addition to gastroenteritis and invasive disease, predominantly attributable to nontyphoidal Salmonella serovars Typhimurium and Enteritidis, are major causes of death and disability across the globe. A broad-spectrum vaccine that protects against disease caused by typhoidal and nontyphoidal serovars of Salmonella is not available for humans but would prevent a considerable burden of disease worldwide.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We previously developed a broad-spectrum vaccine for gram-negative bacteria that is based on the inner core domain of detoxified Escherichia coli O111, Rc (J5) mutant lipooligosaccharide, a highly conserved antigen across gram-negative bacteria, complexed with an outer membrane protein of group B Neisseria meningitidis. In this study, mice and rabbits were immunized with the J5 core\/outer membrane protein subunit vaccine. We assessed the cross-reactivity of antisera with various Salmonella species lipopolysaccharides and the protective efficacy of passive and active immunization with J5 vaccine against experimental nontyphoidal Salmonella infection in mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Vaccination with J5 induced IgG responses that strongly recognized lipopolysaccharide from both typhoidal and nontyphoidal Salmonella and imparted a survival benefit against lethal heterologous challenges with S. Typhimurium and S. Enteritidis. Additionally, passive transfer studies with rabbit hyperimmune sera raised against the J5 vaccine revealed that anti-core antibodies were protective against lipopolysaccharide challenge in D-galactosamine\u2013sensitized mice.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Our findings support the development of core glycolipids as a novel Salmonella vaccine candidate. Further investigation is warranted to determine the efficacy of the J5 core\/outer membrane protein vaccine against other Salmonella serovars of concern.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/infdis\/jiae641","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T15:27:47Z","timestamp":1735572467000},"page":"133-142","source":"Crossref","is-referenced-by-count":3,"title":["A Core Glycolipid Vaccine Elicits Cross-reactive Antibodies Against <i>Salmonella<\/i> Species and Protects Against Invasive Nontyphoidal <i>Salmonella<\/i> Disease in Mice"],"prefix":"10.1093","volume":"232","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2771-1609","authenticated-orcid":false,"given":"Scott M","family":"Baliban","sequence":"first","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1820-7379","authenticated-orcid":false,"given":"Surekha","family":"Shridhar","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kun","family":"Luo","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Kolasny","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang","family":"Hyun","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyong","family":"Zhao","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0651-5748","authenticated-orcid":false,"given":"Sharon M","family":"Tennant","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4362-9936","authenticated-orcid":false,"given":"Alan S","family":"Cross","sequence":"additional","affiliation":[{"name":"Center for Vaccine Development and Global Health, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Medicine, University of Maryland School of Medicine , Baltimore, Maryland ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,12,31]]},"reference":[{"key":"2025073007425881600_jiae641-B1","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive Salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"2025073007425881600_jiae641-B2","doi-asserted-by":"crossref","first-page":"e978","DOI":"10.1016\/S2214-109X(22)00119-X","article-title":"Incidence of typhoid and paratyphoid fever in Bangladesh, Nepal, and Pakistan: results of the surveillance for enteric fever in Asia project","volume":"10","author":"Garrett","year":"2022","journal-title":"Lancet Glob Health"},{"key":"2025073007425881600_jiae641-B3","volume-title":"Global burden of disease 2021: findings from the GBD 2021 study","author":"Institute for Health Metrics and Evaluation (IHME)","year":"2024"},{"key":"2025073007425881600_jiae641-B4","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.ESP-0007-2018","article-title":"Invasive nontyphoidal Salmonella disease in Africa","volume":"8","author":"Gilchrist","year":"2019","journal-title":"EcoSal Plus"},{"key":"2025073007425881600_jiae641-B5","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S1473-3099(21)00615-0","article-title":"Complications and mortality of non-typhoidal Salmonella invasive disease: a global systematic review and meta-analysis","volume":"22","author":"Marchello","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2025073007425881600_jiae641-B6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/650733","article-title":"The global burden of nontyphoidal Salmonella gastroenteritis","volume":"50","author":"Majowicz","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2025073007425881600_jiae641-B7","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial Resistance Collaborators","year":"2022","journal-title":"Lancet"},{"key":"2025073007425881600_jiae641-B8","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1093\/ofid\/ofad041","article-title":"Salmonella combination vaccines: moving beyond typhoid","volume":"10","author":"MacLennan","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"2025073007425881600_jiae641-B9","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.3390\/vaccines11111671","article-title":"Induction of broad immunity against invasive Salmonella disease by a quadrivalent combination Salmonella MAPS vaccine targeting Salmonella enterica serovars Typhimurium, Enteritidis, Typhi, and Paratyphi A","volume":"11","author":"Boerth","year":"2023","journal-title":"Vaccines (Basel)"},{"key":"2025073007425881600_jiae641-B10","first-page":"57","article-title":"On the immunochemistry of the O-antigen of Enterobacteriaceae. VI. Comparison of the sugar components of polysaccharides from S and R forms of Salmonella","volume":"182","author":"Kauffmann","year":"1961","journal-title":"Zentralbl Bakteriol"},{"key":"2025073007425881600_jiae641-B11","doi-asserted-by":"crossref","first-page":"e0004522","DOI":"10.1128\/mmbr.00045-22","article-title":"Hit \u2018em where it hurts: gram-negative bacterial lipopolysaccharide as a vaccine target","volume":"87","author":"Cross","year":"2023","journal-title":"Microbiol Mol Biol Rev"},{"key":"2025073007425881600_jiae641-B12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4049\/jimmunol.111.2.433","article-title":"Treatment of E. coli and Klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant","volume":"111","author":"Ziegler","year":"1973","journal-title":"J Immunol"},{"key":"2025073007425881600_jiae641-B13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/infdis\/158.2.301","article-title":"Immunization with rough mutants of Salmonella Minnesota: initial studies in human subjects","volume":"158","author":"DeMaria","year":"1988","journal-title":"J Infect Dis"},{"key":"2025073007425881600_jiae641-B14","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1056\/NEJM198211113072001","article-title":"Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli","volume":"307","author":"Ziegler","year":"1982","journal-title":"N Engl J Med"},{"key":"2025073007425881600_jiae641-B15","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/infdis\/173.5.1157","article-title":"A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia","volume":"173","author":"Bhattacharjee","year":"1996","journal-title":"J Infect Dis"},{"key":"2025073007425881600_jiae641-B16","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1086\/498167","article-title":"Active immunization with a detoxified endotoxin vaccine protects against lethal polymicrobial sepsis: its use with CpG adjuvant and potential mechanisms","volume":"192","author":"Opal","year":"2005","journal-title":"J Infect Dis"},{"key":"2025073007425881600_jiae641-B17","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00004630-200209000-00006","article-title":"Differential effects of two different routes of immunization on protection against gram-negative sepsis by a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine in a burned mouse model","volume":"23","author":"Neely","year":"2002","journal-title":"J Burn Care Rehabil"},{"key":"2025073007425881600_jiae641-B18","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/1753425908095959","article-title":"Intranasal administration of a detoxified endotoxin vaccine protects mice against heterologous gram-negative bacterial pneumonia","volume":"14","author":"Chen","year":"2008","journal-title":"Innate Immun"},{"key":"2025073007425881600_jiae641-B19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/319297","article-title":"Active immunization with a detoxified Escherichia coli J5 lipopolysaccharide group B meningococcal outer membrane protein complex vaccine protects animals from experimental sepsis","volume":"183","author":"Cross","year":"2001","journal-title":"J Infect Dis"},{"key":"2025073007425881600_jiae641-B20","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1016\/j.vaccine.2015.10.072","article-title":"Phase 1 testing of detoxified LPS\/group B meningococcal outer membrane protein vaccine with and without synthetic CPG 7909 adjuvant for the prevention and treatment of sepsis","volume":"33","author":"Cross","year":"2015","journal-title":"Vaccine"},{"key":"2025073007425881600_jiae641-B21","doi-asserted-by":"crossref","first-page":"4576","DOI":"10.1016\/S0264-410X(03)00483-3","article-title":"Phase I study of detoxified Escherichia coli J5 lipopolysaccharide (J5dLPS)\/group B meningococcal outer membrane protein (OMP) complex vaccine in human subjects","volume":"21","author":"Cross","year":"2003","journal-title":"Vaccine"},{"key":"2025073007425881600_jiae641-B22","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1128\/iai.61.9.3863-3872.1993","article-title":"A broadly cross-protective monoclonal antibody binding to Escherichia coli and Salmonella lipopolysaccharides","volume":"61","author":"Di Padova","year":"1993","journal-title":"Infect Immun"},{"key":"2025073007425881600_jiae641-B23","doi-asserted-by":"crossref","first-page":"e00474-18","DOI":"10.1128\/mSphere.00474-18","article-title":"Improving our understanding of Salmonella enterica serovar Paratyphi B through the engineering and testing of a live attenuated vaccine strain","volume":"3","author":"Higginson","year":"2018","journal-title":"mSphere"},{"issue":"Suppl 4","key":"2025073007425881600_jiae641-B24","doi-asserted-by":"crossref","first-page":"S332","DOI":"10.1093\/cid\/civ729","article-title":"Invasive nontyphoidal Salmonella infections among children in Mali, 2002-2014: microbiological and epidemiologic features guide vaccine development","volume":"61","author":"Tapia","year":"2015","journal-title":"Clin Infect Dis"},{"key":"2025073007425881600_jiae641-B25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.4269\/ajtmh.17-0508","article-title":"Characterization of invasive Salmonella serogroup C1 infections in Mali","volume":"98","author":"Fuche","year":"2018","journal-title":"Am J Trop Med Hyg"},{"key":"2025073007425881600_jiae641-B26","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1093\/infdis\/115.2.131","article-title":"Interaction of Salmonella with phagocytes in vitro","volume":"115","author":"Morello","year":"1965","journal-title":"J Infect Dis"},{"key":"2025073007425881600_jiae641-B27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1128\/br.30.1.192-255.1966","article-title":"Immunochemistry of O and R antigens of Salmonella and related Enterobacteriaceae","volume":"30","author":"Luderitz","year":"1966","journal-title":"Bacteriol Rev"},{"key":"2025073007425881600_jiae641-B28","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.1073\/pnas.76.11.5939","article-title":"Galactosamine-induced sensitization to the lethal effects of endotoxin","volume":"76","author":"Galanos","year":"1979","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025073007425881600_jiae641-B29","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3390\/molecules23071749","article-title":"Immunogenicity and induction of functional antibodies in rabbits immunized with a trivalent typhoid-invasive nontyphoidal Salmonella glycoconjugate formulation","volume":"23","author":"Baliban","year":"2018","journal-title":"Molecules"},{"key":"2025073007425881600_jiae641-B30","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/17534259211007538","article-title":"A pilot study of an anti-endotoxin Ig-enriched bovine colostrum to prevent experimental sepsis","volume":"27","author":"Cross","year":"2021","journal-title":"Innate Immun"},{"key":"2025073007425881600_jiae641-B31","doi-asserted-by":"crossref","first-page":"e0005493","DOI":"10.1371\/journal.pntd.0005493","article-title":"Development of a glycoconjugate vaccine to prevent invasive Salmonella Typhimurium infections in sub-Saharan Africa","volume":"11","author":"Baliban","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073007425881600_jiae641-B32","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijmm.2007.04.002","article-title":"Neutralizing and cross-reactive antibodies against enterobacterial lipopolysaccharide","volume":"297","author":"Muller-Loennies","year":"2007","journal-title":"Int J Med Microbiol"},{"key":"2025073007425881600_jiae641-B33","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1128\/jb.95.4.1343-1349.1968","article-title":"Cross-protection against Salmonella Enteritidis infection in mice","volume":"95","author":"Collins","year":"1968","journal-title":"J Bacteriol"},{"key":"2025073007425881600_jiae641-B34","doi-asserted-by":"crossref","first-page":"34776","DOI":"10.1038\/srep34776","article-title":"Outer membrane vesicles from flagellin-deficient Salmonella enterica serovar Typhimurium induce cross-reactive immunity and provide cross-protection against heterologous Salmonella challenge","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"2025073007425881600_jiae641-B35","doi-asserted-by":"crossref","first-page":"588952","DOI":"10.3389\/fmicb.2020.588952","article-title":"Immunization with outer membrane vesicles derived from major outer membrane protein-deficient Salmonella Typhimurium mutants for cross protection against Salmonella Enteritidis and avian pathogenic Escherichia coli O78 infection in chickens","volume":"11","author":"Chen","year":"2020","journal-title":"Front Microbiol"},{"key":"2025073007425881600_jiae641-B36","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0264-410X(95)00249-Z","article-title":"Protection against oral challenge three months after i.v. immunization of BALB\/c mice with live Aro Salmonella Typhimurium and Salmonella Enteritidis vaccines is serotype (species)-dependent and only partially determined by the main LPS O antigen","volume":"14","author":"Hormaeche","year":"1996","journal-title":"Vaccine"},{"key":"2025073007425881600_jiae641-B37","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3389\/fimmu.2017.01647","article-title":"O-serotype conversion in Salmonella Typhimurium induces protective immune responses against invasive non-typhoidal Salmonella infections","volume":"8","author":"Li","year":"2017","journal-title":"Front Immunol"},{"key":"2025073007425881600_jiae641-B38","doi-asserted-by":"crossref","first-page":"e0010866","DOI":"10.1371\/journal.pntd.0010866","article-title":"Multiple immunodominant O-epitopes co-expression in live attenuated Salmonella serovars induce cross-protective immune responses against S. Paratyphi A, S. Typhimurium and S. Enteritidis","volume":"16","author":"Li","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"key":"2025073007425881600_jiae641-B39","first-page":"E1","article-title":"Overview of the impact of typhoid and paratyphoid fever. Utility of Ty21a vaccine (vivotif(R))","volume":"58","author":"Amicizia","year":"2017","journal-title":"J Prev Med Hyg"},{"key":"2025073007425881600_jiae641-B40","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0140-6736(91)91910-M","article-title":"Oral immunisation against typhoid fever in Indonesia with Ty21a vaccine","volume":"338","author":"Simanjuntak","year":"1991","journal-title":"Lancet"},{"key":"2025073007425881600_jiae641-B41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/S0140-6736(87)90480-6","article-title":"Large-scale field trial of Ty21a live oral typhoid vaccine in enteric-coated capsule formulation","volume":"329","author":"Levine","year":"1987","journal-title":"Lancet"},{"key":"2025073007425881600_jiae641-B42","doi-asserted-by":"crossref","first-page":"e0008783","DOI":"10.1371\/journal.pntd.0008783","article-title":"Homologous and heterologous re-challenge with Salmonella Typhi and Salmonella Paratyphi A in a randomised controlled human infection model","volume":"14","author":"Gibani","year":"2020","journal-title":"PLoS Negl Trop Dis"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiae641\/61299409\/jiae641.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/133\/61299409\/jiae641.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/232\/1\/133\/61299409\/jiae641.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T11:43:11Z","timestamp":1753875791000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/232\/1\/133\/7935185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,31]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12,31]]},"published-print":{"date-parts":[[2025,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiae641","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,7,15]]},"published":{"date-parts":[[2024,12,31]]}}}